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Auxiliary subunits tightly regulate AMPA receptor function in excitatory neurotransmission. Twomey et al. elucidate the structural bases for regulation of desensitization in AMPA receptor complexes, where profound changes in interfaces and symmetry of the synaptic receptor domains dictate gating kinetics.
INTRODUCTION
Ionotropic glutamate receptors (iGluRs) govern fast excitatory synaptic transmission. Activated by glutamate, iGluRs propagate signal transduction by allowing cation flux through their channels, and as a result, rapidly depolarize the membrane of post-synaptic neurons (Traynelis et al., 2010) . The a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) functions on the millisecond timescale and serves as an indicator of synaptic strength. Aberrancies in AMPAR function lead to a broad range of neurodegenerative disorders, from Alzheimer's to Parkinson's diseases (Bowie, 2008; Traynelis et al., 2010) , schizophrenia, epilepsy (Rogawski, 2013) , ischemia-induced trauma (Lo et al., 2003; Oguro et al., 1999) , and fragile-X syndrome (Uzunova et al., 2014) .
Structurally, AMPARs are tetrameric assemblies of subunits with a layered domain architecture (Sobolevsky, 2015) . The extracellular domain (ECD), comprised of the amino terminal domains (ATDs), which play an important role in receptor assembly, and the ligand-binding domains (LBDs), which bind agonists, antagonists, and positive allosteric modulators, extends outward from the postsynaptic membrane into the synaptic cleft. The LBD is made up of two polypeptide stretches (S1 and S2), which are interrupted by segments of the transmembrane domain (TMD) that contains three membrane-spanning helices (M1, M3, and M4), a re-entrant loop M2, and forms a cation-selective ion channel.
However, native AMPARs exist as complexes with transmembrane auxiliary subunits, which tightly regulate AMPAR assembly, trafficking, gating, and pharmacology, and are implicated in AMPAR-related neuropathologies (Jackson and Nicoll, 2011) . While structural details on the AMPAR core have been known, insights into the structures of AMPARs bound to their auxiliary subunits are just beginning to emerge. As shown in two separate cryo-EM studies (Twomey et al., 2016; Zhao et al., 2016) , the transmembrane AMPAR regulatory protein (TARP) g2 or stargazin (STZ), which positively modulates AMPAR trafficking, agonist efficacy, and favors the open state of the channel (Chen et al., 2000; MacLean et al., 2014; Priel et al., 2005; Tomita et al., 2005; Zhang et al., 2014) , assembles with AMPARs through its TMD and extracellular loops that reach to the AMPAR LBD to modulate gating kinetics (Dawe et al., 2016; Tomita et al., 2005) , at variable stoichiometry. While these studies provided important insight into the assembly of native AMPAR complexes in the closed state, the modest resolution of the corresponding cryo-EM reconstructions prevented detailed understanding of AMPAR auxiliary subunit assembly, how auxiliary subunits structurally facilitate changes in gating kinetics, and the mechanism by which auxiliary subunits with different function from STZ assemble around the AMPAR core.
To address these questions, we investigated the structural basis for complex formation between the GluA2 AMPAR and the auxiliary subunit germline-specific gene 1-like (GSG1L) using cryo-EM. Compared to STZ, GSG1L has been more recently identified as an AMPAR auxiliary subunit (Schwenk et al., 2012; Shanks et al., 2012) . GSG1L, similar to TARPs, belongs to the claudin superfamily of tetraspan membrane proteins and is present in brain tissue with peptide counts comparable to TARPs (Schwenk et al., 2012; Shanks et al., 2012) . GSG1L forms a high-affinity complex with AMPARs in the post-synaptic density (Schwenk et al., 2012) , is necessary for long-term potentiation (LTP) (Gu et al., 2016) , synapse formation, and plasticity (Gu et al., 2016; Mao et al., 2017) , and is also implicated in Huntington's disease (Becanovic et al., 2010) . Similar to STZ, GSG1L modestly slows down deactivation and desensitization kinetics in GluA1-and GluA2-containing AMPARs (Schwenk et al., 2012; Shanks et al., 2012) . However, in contrast to STZ, which produces slight acceleration of recovery from desensitization and favors the AMPAR open state (MacLean et al., 2014; Priel et al., 2005; Tomita et al., 2005; Twomey et al., 2016; Zhang et al., 2014) , GSG1L dramatically slows the recovery from desensitization and apparently favors the desensitized state (Schwenk et al., 2012; Shanks et al., 2012) .
RESULTS AND DISCUSSION
Cryo-EM of GluA2-GSG1L Complex in the Presence of Competitive Antagonist To readily form a complex between GluA2 and GSG1L, we utilized a fusion construct design, where GSG1L is covalently linked via its N terminus to the C terminus of GluA2 ( Figure S1A ), similar to our previous study of the GluA2-STZ complex (Twomey et al., 2016) . We also introduced a GSG1L C-terminal truncation that maximized protein expression and homogeneity ( Figures S1B-S1D) . Function of the resulting construct, GluA2- GSG1L, was tested using patch-clamp recordings in HEK cells. Compared to the GluA2 receptor alone, GluA2-GSG1L showed increased contribution of slow components in the desensitization and deactivation kinetics, and more than 10 times slower recovery from desensitization (Figures 1A and S1E-S1I), a hallmark of GSG1L regulation of AMPAR function, consistent with previous results for co-expressed (Gu et al., 2016; Schwenk et al., 2012; Shanks et al., 2012) or fused (Gu et al., 2016; McGee et al., 2015) AMPARs and GSG1L. In addition, the efficacy of the partial agonist kainate (KA) for GluA2-GSG1L (I KA /I 0 = 0.526 ± 0.069, n = 6) was dramatically increased compared to the receptor alone (I KA /I 0 = 0.110 ± 0.027, n = 5), reminiscent of the STZ effect (Tomita et al., 2005) .
In order to provide a structural framework for understanding AMPAR regulation by GSG1L, we pursued cryo-EM experiments with GluA2-GSG1L in the presence of the competitive antagonist ZK200775 (ZK). Two-dimensional class averages revealed structural details of the complex, from visible inter/ intra-dimer interfaces to helices in the GluA2 and GSG1L TMDs ( Figure 1B) . Through refining the reconstruction from the best group of particles ( Figure S2A ), we obtained a map of the double-bound state, GluA2-2xGSG1L ZK , at 4.6 Å resolution, according to Fourier shell correlation (FSC) between two half maps ( Figures 1C and S3 ). Similar to cryo-EM reconstructions of the antagonist-bound GluA2-STZ complex (Twomey et al., 2016) , we also observed varying stoichiometry of the GluA2-GSG1L complex ( Figure S3 ) with a single GSG1L-bound state (GluA2-1xGSG1L ZK ) reaching 8.3 Å resolution and a receptor unbound state (GluA2-0xGSG1L ZK ) reaching 7.8 Å resolution ( Figure S2A ).
Architecture and Assembly of the GluA2-GSG1L Complex in the Closed State The GluA2-2xGSG1L ZK model was built and real-space refined ( Figure S4 ) and has 2-fold rotational symmetry (Figure 2 ). Individual GSG1L subunits bind to either GluA2 subunits A and B or C and D in the TMD, spanning 70 Å from the bottom of the TMD to the top of its extracellular head, which sits between the LBD dimers (Figures 2A-2C ). The presence of two GSG1L protomers extends the width of the GluA2 TMD from 55 Å to 90 Å . Similar to the claudin tight-junction proteins (Saitoh et al., 2015; Suzuki et al., 2014) , GSG1L is comprised of a bundle of four a helices (TM1-TM4), with an extracellular head domain, formed by polypeptides connecting TM1 to TM2 and TM3 to TM4, that includes a five-stranded b sheet, which sits atop the bundle ( Figure 2D ). TM3 and TM4 form an extended, largely hydrophobic interface with the TMD helices M1 of GluA2 subunits A/C and M4 of GluA2 subunits B/D, respectively (Figures 2E and 2F) .
The GSG1L head domain includes the 49-amino-acids-long b1-b2 loop, which represents a key difference between GSG1L and TARPs ( Figure S5 ). Most of this loop was not present in our cryo-EM density, suggesting its highly dynamic nature. However, an additional, non-AMPAR density was observed adjacent to the LBD helix H in GluA2 subunits A and C, in close proximity ($17 Å ) to the tips of GSG1L b1 and b2 ( Figure 2G ). This density appeared only in the presence of bound GSG1L (data not shown) and likely represents a portion of the b1-b2 loop stabilized by binding to the GluA2 LBD.
Domain-Specific Regulation of Gating by Auxiliary Subunits
Putative direct binding to GluA2 LBD subunits A and C by the b1-b2 loop, which is much shorter in STZ compared to GSG1L (17 versus 49 residues; Figure S5 ), was not observed in the recent structures of the GluA2-STZ complex (Twomey et al., 2016; Zhao et al., 2016) . In fact, the negatively charged b4-TM2 loop of STZ was postulated to play a key role in regulating AMPAR activation. The corresponding region in GSG1L has a single negatively charged residue versus six in STZ. In order to test whether different domains of auxiliary subunits mediate specific regulation of AMPAR function, we constructed chimeras between GSG1L and STZ and functionally tested the corresponding fusions with GluA2 using patch-clamp recordings (Figure 3 ). Similar to GluA2-GSG1L and GluA2-STZ, the chimeric fusions showed greatly increased efficacy of KA ( Figure 3E ), not only indicating assembly of proper, functional complexes, but also suggesting that the usage of partial agonist efficacy as a marker for AMPAR assembly with TARPs (Cho et al., 2007; Tomita et al., 2005) can be extended to a broader range of AMPAR auxiliary subunits. Given the striking similarity in TMD positioning of GSG1L and STZ relative to GluA2 ( Figures 3A and 3B) , we hypothesize that the TMD of these auxiliary subunits represents the main domain responsible for enhancement of partial agonist efficacy. Both GSG1L and STZ are likely to exert such a strong effect on AMPAR function through the pronounced interfaces between TM3 and TM4 and M1 of GluA2 subunits A and C and M4 of GluA2 subunits B and D, as well as via less pronounced contacts between TM4 and M2 of GluA2 subunits A and C (Figure 2F) , which directly contributes to the AMPAR permeation pathway. Similar to TARPs (Ben-Yaacov et al., 2017) , GSG1L might use these interfaces to destabilize the AMPAR closed state. In addition, the intracellular C terminus of GluA2, excluded from our studies by nature of the construct design, may also play an active role in GSG1L-AMPAR interaction (Ben-Yaacov et al., 2017). Similarity in the TMD interfaces between GluA2 and GSG1L/STZ also suggests possibility of higher occupancy states with three or four GSG1L subunits bound to GluA2, as exemplified by the GluA2 complex bound to four STZ subunits (Zhao et al., 2016) .
Replacement of the long b1-b2 loop of GSG1L with the shorter loop of STZ (G-b1b2Lp-S construct) largely eliminated deceleration of recovery from desensitization caused by GSG1L ( Figure 3F ). Interestingly, insertion of the b1-b2 loop of GSG1L into STZ (S-Ex1-G and S-b1b2Lp-G constructs) did not cause dramatic deceleration of recovery from desensitization, indicating the importance of the GSG1L scaffold for the functional effect of the b1-b2 loop. Nevertheless, our functional experiments supported the idea that the long b1-b2 loop represents a GSG1L domain critically important for slowing AMPAR recovery from desensitization.
One of the key effects of STZ on AMPAR function is increasing the open channel probability (Tomita et al., 2005) , which is reflected in an increased fraction of non-desensitized receptors (I SS /I 0 ). Increased I SS /I 0 was observed for GluA2-STZ fusions with an intact b4-TM2 loop (GluA2-STZ and S-b1b2Lp-G constructs; Figure 3 ). In contrast, constructs containing the b4-TM2 loop from GSG1L had I SS /I 0 comparable to wild-type GluA2 or smaller, supporting the idea that the negatively charged b4-TM2 loop of STZ represents a domain that increases AMPAR open channel probability. Notably, charge substitution in b3 of GSG1L (G-SL construct) resulted in reduced I SS /I 0 , suggesting enhancement of desensitization. Overall, our chimera experiments support the idea that auxiliary subunits share a modular structural design and use a common scaffold to produce similar effects on AMPAR function. Nevertheless, functional effects of distinct structural modules may not be explicit, as also suggested by recent chimeric studies (Ben-Yaacov et al., 2017) .
Structure of the GSG1L-Stabilized Desensitized State
In the absence of auxiliary subunits, structural determination of the AMPAR desensitized state has been a challenge-cryo-EM reconstructions did not exceed 20 Å resolution and showed a highly dynamic ECD (D€ urr et al., 2014; Meyerson et al., 2014; Nakagawa et al., 2005) . We surmised that the presence of GSG1L, which dramatically slows down recovery from desensitization, might help to structurally stabilize a desensitized receptor conformation. Similar to GSG1L, high-potency agonists have also been shown to slow the recovery from desensitization (Zhang et al., 2006) . Using a double-pulse patch-clamp protocol ( Figure 4A ), we tested whether we can use both the presence of GSG1L and high-potency agonists to decelerate the recovery from desensitization to a greater extent. For wild-type GluA2, the higher-affinity full agonist L-quisqualate (Quis) increased the time constant of recovery from desensitization to 121 ms compared to 15.3 ms for glutamate ( Figures 4B and S1 ). In the presence of GSG1L, Quis further slowed down recovery from desensitization (836 ms compared to 164 ms for glutamate), confirming that the two factors can be used in concert. Therefore, in order to obtain structural insight into the mechanism of AMPAR desensitization, we used cryo-EM to visualize GluA2-GSG1L in the presence of Quis ( Figure S2B ). We used the best group of particles to reconstruct a refined map of a double GSG1L-bound state, GluA2-2xGSG1L Quis , at 8.4 Å resolution ( Figure S3 ). Guided by clearly resolved cryo-EM density for the core of the complex ( Figure S6 ), we built a model of GluA2-2xGSG1L Quis ( Figures 4C and 4D ) using the high-resolution structures of the ATD (Jin et al., 2009 ), Quis-bound LBD (Jin et al., 2002) , and TMD from our GluA2-2xGSG1L ZK structure. Immediately apparent were the striking conformational changes that resulted in the shorter, balloon-like structure of GluA2-2xGSG1L Quis ( Figure 4D ) compared to the taller Y-shaped structure of GluA2-2xGSG1L ZK ( Figure 2B ).
Conformational Changes in the Desensitized State
The overall rearrangement of the receptor to the balloon-like shape is signified by altered conformations of the LBD clamshells (Armstrong and Gouaux, 2000; Landes et al., 2011) , which are 26 more closed in the Quis-bound LBDs compared to the ZK-bound LBDs ( Figure 5A ). The large degree of LBD clamshell closure, coupled with a closed, non-conducting pore similar to GluA2-2xGSG1L ZK , is consistent with GluA2-2xGSG1L Quis representing a desensitized state. To accommodate strong conformational changes in individual LBDs, and to simultaneously maintain the closed-channel conformation of TMD, LBD dimers undergo dramatic rearrangements ( Figure 5B ). These rearrangements include a relative $6 Å translation and 31 rotation of the upper (D1) lobes in each A/D and B/C LBD dimer. As a result, the D1 lobes become largely separated ( Figure 5B , upper row), while the LBD D2 portions remain connected to the ion channel with approximately the same spatial arrangement as in the closed state GluA2-2xGSG1L ZK structure . At the same time, the GluA2-2xGSG1L Quis LBD dimers lose their local 2-fold rotational symmetry and the intradimer interface Similar changes in the LBD dimer were previously observed in the crystal structures of isolated LBDs (S1S2 constructs) crosslinked via substituted cysteines G725C and S729C (Armstrong et al., 2006) (Figure S7 ). These crosslinks resulted in similar LBD lobe separation to what we see in GluA2-2xGSG1L Quis , which is distinct from the resting/closed and pre-active/active states of the full-length receptor and isolated domains (Armstrong and Gouaux, 2000; D€ urr et al., 2014; Jin et al., 2003; Jin et al., 2002; Meyerson et al., 2014; Poon et al., 2011; Sobolevsky et al., 2009; Yelshanskaya et al., 2014 Yelshanskaya et al., , 2016b (Figure 5C ). Given the apparent strengthening of desensitization in AMPARs carrying G725C and S729C substitutions (Armstrong et al., 2006; Plested and Mayer, 2009; Yelshanskaya et al., 2014) and weakening of desensitization by positive allosteric modulators and mutations at the D1-D1 interface (Gonzalez et al., 2010; Jin et al., 2005; Nayeem et al., 2009; Priel et al., 2006; Stern-Bach et al., 1998; Sun et al., 2002; Weston et al., 2006) , such similarities support the idea that the GluA2-2xGSG1L Quis structure represents a desensitized state. The latter conclusion is also consistent with transformation of the LBD layer assembly in GluA2-2xGSG1L ZK toward its more 4-fold symmetrical arrangement in GluA2-2xGSG1L Quis ( Figures 6E, 6F , and 6K), similar to the desensitized structure of GluK2 (Meyerson et al., 2014 (Meyerson et al., , 2016 .
Despite the similarity in symmetry between the desensitized GluK2 and GluA2-2xGSG1L Quis LBD layer assemblies, the structural rearrangements of domains in the two types of iGluRs are quite distinct. We compared three iGluR structures obtained in the presence of agonists, at conditions apparently favoring desensitization (Figure 7) . Compared to the GluA2 NOW structure of GluA2 in complex with the partial agonist nitrowillardiine (NOW), which has an intact interface between the upper lobes of its LBD dimers and might represent an agonist-bound closed state (Yelshanskaya et al., 2014) (Figures 7B and 7E) , the LBD layer arrangement in GluA2-2xGSG1L Quis leaves the B/D LBDs at essentially the same positions, while the A/C LBDs rotate away from them, approximately around the axis of the GluA2 overall 2-fold rotational symmetry ( Figures 7A and 7D ). In contrast, the A/C LBDs in GluK2 bound to the full agonist (2S,4R)-4-methylglutamate are at similar positions as in the GluA2 NOW structure but the B/D LBDs rotate clockwise by 125 around their own axes ( Figures 7C and 7F ), presenting completely different surfaces at the intersubunit interfaces. As a result, helices E and G in the B/D LBDs, which do not contribute to intersubunit interfaces in the GluA2 structures, combine with helices E and G in subunits A and C of GluK2 to assemble a pseudo 4-fold symmetric ''desensitization ring'' in the center of the LBD layer (Meyerson et al., 2016) (Figure 7F ). Such a dramatic rearrangement of LBDs in GluK2 allows the M3 transmembrane segments in subunits B and D to adopt similar secondary structures as in subunits A and C ( Figure 7I ). In contrast, the large separation of the B/D subunit E helices in the GluA2 structures requires longer M3-S2 linkers and, as a result, the M3 helices in the GluA2 subunits B and D are one turn shorter than in subunits A and C ( Figures 7G and 7H ). Thus, despite superficially similar overall transformations of symmetry in the LBD layer, the iGluR AMPAR and KAR subtypes display entirely different structural mechanisms of desensitization. Further studies are required to figure out whether these mechanisms are subtype specific or can be present in different iGluR subtypes.
The overall rearrangement of the LBD layer in GluA2-2xGSG1L Quis ( Figures 6E, 6F , and 6K) is a result of asymmetrical displacement of the diagonal LBD protomers, with the B and D protomers maintaining similar positions relative to the GluA2-2xGSG1L ZK structure and the A and C protomers rotating away from them. Since the ATD layer is tightly connected to the LBD layer through ATD-LBD interfaces in subunits A and C, the translation and rotation of the top portions of the LBDs from subunits A and C is reflected in rearrangements in the ATD. The ATD tetramer moves nearly as a rigid body, translating 5 Å downward and rotating by 18 ( Figure 6 ). Consistent with recent functional, mutagenesis, LRET and smFRET experiments (Shaikh et al., 2016; Yelshanskaya et al., 2016a) , the ATD interdimer interface remains largely intact ( Figure S6D ), with the cross-dimer distance between G212 Cas staying approximately the same in GluA2-2xGSG1L ZK (5.9 Å ) as in GluA2-2xGSG1L Quis (5.6 Å ), and the dimers rotating away from each other only slightly (by $4 cumulatively). For both GluA2-2xGSG1L ZK and GluA2-2xGSG1L Quis , we did not observe separation of ATD dimers in our 3D classification at any stage in the image processing ( Figure S2 ). Such separation, observed previously for the intact receptors (D€ urr et al., 2014; Meyerson et al., 2014; Nakagawa et al., 2005) , leaves open the possibility that desensitized AMPARs, in the absence of auxiliary subunits and with intact ATD-LBD linker, may have a more diverse conformational ensemble.
Recovery from Desensitization
Comparison of the GluA2-GSG1L structures in desensitized (GluA2-2xGSG1L Quis ) and closed (GluA2-2xGSG1L ZK ) states provides an approximation of conformational changes that might happen during recovery from desensitization (desensitized-toclosed state transition) (Movie S1 and Figure 6 ). We hypothesize that upon recovery, the LBD clamshells open and release agonist, their D1 lobes rotate 31 backward to restore the local 2-fold rotational symmetry of the LBD dimers. This shifts the less 4-fold symmetrical arrangement of the LBD tetramer, where the protomers A and C rotate by 14 in the plain parallel to membrane back toward protomers B and D. Following restoration of the LBD layer, the ATD layer raises 5 Å upward into the synaptic cleft and rotates 18 counterclockwise when viewed extracellularly. In contrast, the LBD-TMD linkers and the TMD remain relatively unchanged. This view on recovery from desensitization is largely oversimplified and does not account for asynchronous contribution of individual subunits as well as possibility that LBD dimer interfaces can reassemble before the LBDs open and release agonist (Robert and Howe, 2003) .
Recovery from desensitization is slowed by the auxiliary subunit GSG1L assembling with AMPARs through the TMD and modulating gating through cross-subunit interaction of its extracellular b1-b2 loop with the LBDs of AMPAR subunits A and C. The LBDs from subunits A and C are the ones that undergo the most dramatic rearrangement between the desensitized and closed states, suggesting that the GSG1L b1-b2 loop might help to stabilize the loss of local symmetry in the LBD and overall LBD rearrangement in the desensitized state, or perhaps to increase the energetic barrier for conformational transition from the desensitized state to the resting state.
Our findings help to better understand the structural bases of desensitization, a key AMPAR gating process that shapes excitatory neurotransmission. Since desensitization represents a natural self-inhibitory mechanism for AMPARs to suppress their own activity and to protect neurons from the excitotoxic calcium (I-L) Relative positioning of Ca atoms for selected residues shown as blue (GluA2-2xGSG1L ZK ) and orange (GluA2-2xGSG1L Quis ) spheres in the views parallel to the membrane (I) and along the axis of the overall 2-fold symmetry on the layers of ATD (J), LBD (K), and TMD (L). The selected residues are asparagine N10 at the top of the ATD, threonine T394 at the top of the LBD and at the end of the ATD-LBD linker, lysine K505, serine S635, and glycine G771 at the bottom of the LBD, at the beginning of the S1-M1, at the end of M3-S2, and at the beginning of the S2-M4 linkers, respectively. Note, dramatic conformational changes are observed in the ATD and at the top of the LBD layer, while the bottom of the LBD layer and the TMD are nearly identical. See also Movie S1.
overload, enhancing or weakening desensitization might be an effective way to regulate AMPAR activity in pathological conditions. New structural insights might therefore help in developing new therapeutic strategies for treatment of a wide variety of neurological disorders. While the changes accompanying the desensitized states transition), and what the role of auxiliary subunits in these processes remain to be determined.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
ACKNOWLEDGMENTS
We thank Bernd Fakler (University of Freiburg) for providing the GSG1L cDNA, and Z.H. Yu, C. Hong, and R. Huang for assistance with data collection at the HHMI Janelia Research Campus, H. Kao (J.F. Lab) for computational support, Israel S. Fernandez (Columbia University) for lending computational resources and processing advice, M. Fislage (J.F. lab) and F. Acosta-Reyes (J.F. Lab) for processing advice. We are grateful for manuscript edits and comments provided by A.K. Singh (A.I.S. lab) and A.G. Malyutin (J.F. lab). E.C.T. is currently supported by NIH (F31 NS093838) and was supported by NIH training grants (T32 GM008224 and GM008281) for part of this work. A.I.S. is supported by NIH (R01 NS083660, R01 CA206573), the Pew Scholar Award in Biomedical Sciences, and the Irma T. Hirschl Career Scientist Award. J.F. is supported by the Howard Hughes Medical Institute and NIH (R01 GM029169).
STAR+METHODS KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Alexander I. Sobolevsky (as4005@cumc.columbia.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Cultured Cells
Human Embryonic Kidney 293 (HEK293) cells were used for patch-clamp electrophysiology. Cells were obtained from ATCC and were not further authenticated. Cells were grown and maintained using standard protocols at 37 C with 5% CO2, in DMEM media (Corning) supplemented with 10% heat inactivated fetal bovine serum (Crystalgen). Before recordings, cells were plated on glass coverslips in 35 mm dishes and transiently transfected with 1-5 mg of plasmid DNA using Lipofectamine 2000 Reagent (Invitrogen). Cells were passed twice a week and were used until the 30th passage.
HEK293S GnTI À cells were used to express protein for cryo-EM. Cells were obtained from ATCC and were not further authenticated. Cells were grown and maintained at 37 C and 5% CO 2 using standard protocols, in Freestyle 293 media (GIBCO) supplemented with 2% heat inactivated fetal bovine serum (Crystalgen). Cells were passed twice a week and were used until the 30th passage.
Sf9 insect cells were used to make baculovirus for infecting HEK293S GnTI À cells. Cells were obtained from GIBCO and were not further authenticated. Cells were grown and maintained at 27 C using standard protocols, in Sf-900 III SFM (GIBCO). Cells were passed twice a week and were used until the 30th passage.
METHOD DETAILS Construct
The fusion construct, GluA2-GSG1L, used for cryo-EM was prepared by introducing a single GTG linker between rat GluA2 and mouse GSG1L ( Figure S1A ). GluA2 in the construct was based on GluA2* (Yelshanskaya et al., 2014) , flip isoform (Hollmann et al., 1989; Kein€ anen et al., 1990) , including the native signal peptide, with 36 residues deleted from the C terminus, six residues deleted from the ATD-LBD polypeptide linker (L378, T379, L381, P382, S383 and G384; numbered according to the mature polypeptide sequence) and three of four predicted N-linked glycosylation sites knocked-out (N235E, N385D and N392Q), in addition to R586Q at the Q/R editing site (Sommer et al., 1991) to stabilize the tetrameric state.
A similar tandem construct was used to solve the structure of the GluA2-STZ complex, as well as for functional experiments between GluA2 and STZ, as well as GluA2 and GSG1L. To optimize expression and biochemical behavior, the C terminus of GSG1L was truncated to the end of where we predicted TM4 to be via sequence alignment, at F237 (Figures S1A and S5D ). We included a C-terminal eGFP for FSEC (Kawate and Gouaux, 2006) profiling and monitoring during expression and a streptavidin affinity tag for purification purposes. Amino acids T-G-G were included between the C terminus of GSG1L and a thrombin cleavage site (L-V-P-R-G-S). This construct was introduced into a pEG BacMam vector (Goehring et al., 2014) for baculovirus expression in HEK293 cells.
Electrophysiology DNA encoding wild-type GluA2, GluA2-GSG1L (described in the Construct section) or GluA2-STZ (Twomey et al., 2016) was introduced into a plasmid for expression in eukaryotic cells that was engineered to produce green fluorescent protein via a downstream internal ribosome entry site (Yelshanskaya et al., 2014) . HEK293 cells grown on glass coverslips in 35 mm dishes were transiently transfected with 1-5 mg of plasmid DNA using Lipofectamine 2000 Reagent (Invitrogen). Recordings were made 24 to 96 hr after transfection at room temperature. Currents from whole cells, typically held at a À60 mV potential, were recorded using Axopatch 200B amplifier (Molecular Devices, LLC), filtered at 5 kHz and digitized at 10 kHz using low-noise data acquisition system Digidata 1440A and pCLAMP software (Molecular Devices, LLC). The external solution contained (in mM): 140 NaCl, 2.4 KCl, 4 CaCl 2 , 4 MgCl 2 , 10 HEPES pH 7.3 and 10 glucose; 7 mM NaCl was added to the extracellular activating solution containing 3 mM L-glutamate (Glu). The internal solution contained (in mM): 150 CsF, 10 NaCl, 10 EGTA, 20 HEPES pH 7.3. Rapid solution exchange was achieved with a two-barrel theta glass pipette controlled by a piezoelectric translator. Typical 10%-90% rise times were 200-300 ms, as measured from junction potentials at the open tip of the patch pipette after recordings. Since we recorded GluA2-mediated currents in wholecell mode, the time constants of deactivation and desensitization were somewhat larger than the corresponding values measured using outside-out recordings (Alsaloum et al., 2016; Carbone and Plested, 2012; Robert et al., 2005; Weston et al., 2006; Yelshansky et al., 2004) . Nevertheless, despite the apparent overestimation of the absolute values of these parameters, we believe that the differences in kinetics of the corresponding constructs are faithfully reflected in the data. Data analysis was performed using the computer program Origin 9.1.0 (OriginLab). Recovery from desensitization recorded in two-pulse protocols was fitted with the Hodgkin-Huxley equation (Robert and Howe, 2003) :
, where I is the peak current at a given interpulse interval, t, I max is the peak current at long interpulse intervals, t RecDes is the recovery time constant and m is an index that corresponds to the number of kinetically equivalent rate-determining transitions that contribute to the recovery time course.
Expression and purification
The GluA2-GSG1L bacmid and baculovirus were made using standard methods (Goehring et al., 2014) . P2 virus was added to HEK293 GnTI À cells at 37 C and 5% CO 2 , which were grown in Freestyle 293 media (GIBCO) supplemented with 2% fetal bovine serum, heat inactivated (Crystalgen). At 12 hr post-infection, 10 mM sodium butyrate was added the temperature was changed to 30 C. At 72 hr post-infection, cells were collected by low-speed centrifugation (4,000 rpm, 15 min). Cells were then washed with PBS pH 8.0 and pelleted with low speed centrifugation (4,000 rpm, 15 min). The washed cells were lysed with a Misonix sonicator (18 3 10 s, power level 7) in a 150 mM NaCl, 20 mM Tris-HCl (pH 8.0) containing protease inhibitors (0.8 mM aprotinin, 2 mg/ml leupeptin, 2 mM pepstatin A and 1 mM phenylmethysulfonyl fluoride) -50 mL was used per 1 L HEK293 cells. Following, the lysate was clarified after centrifugation (8,000 rpm, 15 min), and the membranes were collected by ultracentrifugation (40,000 rpm, 40 min). The membranes were collected and mechanically homogenized, then solubilized for two hours in 150 mM NaCl, 20 mM Tris-HCl pH 8.0, 20 mM C 12 M (n-dodecyl-b-D-maltopyranoside). Insoluble material was removed by ultracentrifugation (40,000 rpm, 40 min). Streptavidin-linked affinity resin was added to the soluble material (1 mL resin per 1 L cells), and left to bind for 10-14 hr. The resin was washed with 10 column volumes of 150 mM NaCl, 20 mM Tris-HCl pH 8.0, 1 mM C 12 M. Elution was done with the same buffer but supplemented with 2.5 mM D-desthiobiotin. The sample was then concentrated and digested with thrombin (1:200 mass ratio of thrombin to eluted protein) for 2 hr at 22 C. The sample was then loaded onto a size-exclusion chromatography column (Superose-6, 10/300 GL) equilibrated with 150 mM NaCl, 20 mM Tris-HCl pH 8.0, 1 mM C 12 M and 0.01 mg/ml lipid -3:1:1 POPC:POPE:POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, and 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]). The peak fractions were pooled for cryo-EM specimen preparation, and concentrated to 5 mg/ml. All steps, unless otherwise noted, were performed at 4 C.
Cryo-EM sample preparation and data collection C-flat (Protochips, Morrisville, NC) CF-1.2/1.3-2Au 200 mesh holey carbon grids were coated with gold using gold wire and an Edward Auto 306 evaporator. Carbon was removed using Ar/O 2 (6 min, 50 W, 35.0 sccm Ar, 11.5 sccm O 2 ) plasma treatment with a Gatan (Pleasanton, CA, USA) Solarus 950 advanced plasma system, making Au 1.2/1.3 holey /on Au mesh grids (Russo and Passmore, 2014) . In order to make the surface hydrophilic prior to sample application, the grid surface was plasma-treated with H 2 /O 2 (20 s, 10 W, 6.4 sccm H 2 , 27.5 sccm O 2 ). Frozen-hydrated grids were prepared using a Vitrobot Mark IV (FEI, Hillsboro, OR, USA). 3 ml of sample (5 mg/ml GluA2-GSG1L with 0.3 mM antagonist ZK200775) was applied to the plasma-treated grids using 1.0 s blotting time, 3 blot force, 20.0 s wait time and 100% humidity at 22 C. For the desensitized state, 3 ml 5 mg/ml GluA2-GSG1L was quickly added to 0.5 ml 7 mM L-Quisqualate (final concentration 1 mM), and pipetted up-and-down. 3 ml of this mixture was added to the grid, blotted as described above but with 2 s wait time.
The GluA2-GSG1L ZK-bound data were collected on a C s -corrected Titan Krios cryo-electron microscope (FEI) operating at 300 kV, using SerialEM (Mastronarde, 2005 ) with a post-GIF quantum energy filter (20 eV slit) and Gatan K2 Summit direct electron detection (DED) camera (Gatan, Pleasanton, CA, USA) operating at a super-resolution pixel size of 0.52 Å /pixel. A dose rate of 10 e À physical pixel À1 s À1 (total dose of $80 e À Å 2 ) was used across 40 frames (0.2 ms per frame), within the defocus range of À1.5 mm to À3.5 mm. The GluA2-GSG1L quisqualate-bound data were collected on a Tecnai F30 Polara (FEI) microscope operating at 300 kV, using Leginon (Suloway et al., 2005 ) with a Gatan K2 Summit DED camera with a super-resolution pixel size of 0.49 Å . Data were collected across 40 frames (0.2 s per frame), with a dose rate of 8 e À pixel À1 s À1 (total dose of $67 e À Å À2 ), within defocus range of À2 mm to À4.0 mm, C s 2.26 mm.
Image processing
For the antagonist-bound data, super-resolution movies were gain-corrected and binned two-fold in Fourier space to a pixel size of 1.04 Å /pixel. Motion correction and dose-weighted filtering was performed across all frames with Unblur and Summovie (Grant and Grigorieff, 2015) . Defocus values were estimated using CTFFIND4 (Rohou and Grigorieff, 2015) . Further image processing on 6,926 dose-filtered micrographs was performed in RELION (Scheres, 2012) . Approximately 1,000 particles were manually picked for reference-free 2D classification. Six classes were used as references for autopicking (Scheres, 2015) . Autopicking parameters were optimized with figure-of-merit values on a subset of 15 micrographs; a picking threshold of 0.35 was used to ensure all particles were picked. After autopicking, selected particles were initially sorted by 2D classification. A 30 Å low-pass filtered map of GluA2-STZ (Twomey et al., 2016) was used as the reference for 3D classification and auto-refinement (using RELION image handler). A total of 382,980 particles were picked, then, after cleaning through 2D classification (regularization parameter, T = 2), 357,482 particles remained. These particles were subjected to 3D classification (T = 4, no symmetry imposed), and three classes, numbering 159,269 particles were subjected to further image processing. Three-dimensional sub-classification into ten classes (T = 4) resulted in three classes resembling a double-bound GSG1L state (67,852 particles), with remaining classes being different GSG1L-bound stoichiometric states, or low-resolution groups of particles. The double-bound particles initially refined, with C2-symmetry imposed, to 4.9 Å resolution. To further improve the map, these particles were sub-classified into ten classes with C2-symmetry imposed (T = 4). Three classes showing the best details were grouped together, 42,637 particles, and refined to 4.6 Å resolution (with twofold rotational symmetry imposed). Angular distribution shows complete coverage of the particle views, but with side views of the receptor complex more prevalent than top or bottom views ( Figure S4 ). To elucidate the remaining stoichiometric states (single-bound, unbound GSG1L), we revisited the secondary 3D sub-classification into ten classes. Refining two separate classes from here, comprised of 16,454 and 14,372 particles, resulted in reconstructions of the single-bound (8.3 Å , C1-symmetry) and unbound (7.8 Å , C2-symmetry) receptor, respectively ( Figures S3 and S4) .
For the quisqualate-bound state, super-resolution movie stacks were gain-corrected and binned twice in Fourier space, and alignment and dose-weighting was carried out in MotionCor2 (Zheng et al., 2017) . CTF correction, with gCTF (Zhang, 2016) , was performed on non-dose-weighted micrographs, with all further processing on dose-weighted micrographs. A total of 6,778 micrographs were subjected to further image processing in RELION 2.0 (Kimanius et al., 2016) , 2,000 particles were manually picked, and six references from 2D classification of these particles were chosen as references for autopicking. The particles seemed to be spread out more in thicker ice with some aggregates, and the program had trouble picking all particles at a typical threshold level of 0.3-0.4. We used a lower threshold (0.1) for autopicking, resulting in 902,470 particles being chosen. For faster processing, we twice-binned the particle images to 1.96 Å /pixel and subjected the particles to 2D classification, which resulted in 890,667 particles after cleanup. In 3D classification (T = 4, with GluA2-GSG1L ZK filtered to 40 Å as a reference), we used ten classes, with the three best classes appearing to be double-bound with GSG1L and totaling 162,281 particles. The resulting $10 Å map appeared to show conformational change in the GluA2 ATD and LBD, as well as receptor compression ( Figure S2 ).
As this conformation was different compared to the GluA2-GSG1L ZK-bound state, we repeated 3D classification of the 890,667 particles, but instead of using the ZK-bound map as the reference, we used our new quisqualate 9.3 Å reconstruction filtered to 40 Å , and we used 20 classes instead of 10. Surprisingly, no classes showed signs of the ATD-splaying, which some structural studies have reported as a hallmark of receptor desensitization. The five best classes from this sub-classification, totaling 191,778 particles, were sub-classified again into twenty classes. Here, different stoichiometry states and conformational differences were more visible, though there was still no evidence of ATD-splaying (D€ urr et al., 2014; Meyerson et al., 2014; Nakagawa et al., 2005) . The best classes, 82,655 particles resembling a double-bound GSG1L state, were unbinned back to 0.98 Å /pixel and refined to 9.0 Å , with 2-fold rotational symmetry imposed. To further separate the conformational heterogeneity in the ECD from the GSG1L stoichiometry and put particles into a more homogeneous group, we carried out signal subtraction (Bai et al., 2015) of the complex TMD on the 82,655 particles to focus three-dimensional classification (T = 4) on the ECD. A single class, 51,130 particles, was refined to 8.4 Å , giving us the GluA2-2xGSG1L desensitized state. Angular coverage, in contrast to the ZK-bound state, showed higher prevalence of top/bottom views due to collection in thicker ice ( Figure S6 ), similar to our previous investigation of the GluA2-STZ complex (Twomey et al., 2016) . Reconstructions from other classes and stoichiometric states were of insufficient resolution and/or angular coverage to be considered further (Figures S2 and S3) .
The resolution was estimated using the FSC = 0.143 criterion (Scheres and Chen, 2012) between independent half maps on corrected FSC curves in which the influences of the mask were removed (Chen et al., 2013) . All maps were postprocessed using a soft mask in RELION, and B-factors for map sharpening were automatically estimated ( Figure S3 ). All visualization of EM densities was done in UCSF Chimera (Pettersen et al., 2004) , and local resolution estimation was performed in ResMap (Kucukelbir et al., 2014) .
Model Building
To build GluA2-2xGSG1L ZK we individually isolated the ATD and LBD dimers, as well as the TMD, from the full-length ZK-bound crystal structure and fit them into the 4.6 Å cryo-EM reconstruction using rigid-body fitting in COOT (Emsley et al., 2010) . For GSG1L, we made an initial model in SWISS-MODEL (Biasini et al., 2014) , based on the crystal structure of claudin-19 and models of STZ from cryo-EM. The resulting homology model was rigid-body fit into the GluA2-2xGSG1L ZK density, and secondary structure was redefined based on the density and available side chain features along the GluA2-GSG1L interface and sequence alignment. The resulting model was refined against an un-filtered half map in real space with constraints using PHENIX (Afonine et al., 2012) . The refined model was tested for overfitting ( Figure S4 ) by shifting the coordinates with shake in PHENIX and building a density in EMAN2 (Tang et al., 2007 ) from the shaken model. FSC was calculated between the densities from the shaken model, each unfiltered half map and unfiltered sum map, using EMAN2. The resulting GluA2-2xGSG1L ZK model was used as a basis to build GluA2-1xGSG1L ZK and GluA2-0xGSG1L ZK by removing GSG1L subunits as needed and rigid body fits of the overall models into the GluA2-1xGSG1L ZK and GluA2-0xGSG1L ZK cryo-EM densities. To properly compare assembly of GSG1L to STZ around the GluA2 core of the complex (Figure 3) , we carried out real-space refinement with the map and model from the GluA2-1xSTZ complex (Twomey et al., 2016) .
For GluA2-2xGSG1L Quis , we rigid-body fit the high-resolution structures of the ATD (Jin et al., 2009 ) and quisqualate-bound LBD (Jin et al., 2002) , and the TMD from our refined GluA2-2xGSG1L ZK structure in COOT. Structures were visualized and figures were prepared in Pymol.
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